Overall, MajesTEC-3 signals a meaningful step forward for combination bispecific therapies in multiple myeloma, while ...
Early phase 1 data suggest that in vivo, off-the-shelf CAR T therapy may be feasible in multiple myeloma, offering the promise of faster, less toxic treatment without lymphodepletion while raising ...
Tecvayli and Darzalex combination shows unprecedented progression-free survival in relapsed/refractory multiple myeloma, ...
“Tecvayli Treatment Combo Improves Outcomes in Relapsed/Refractory Myeloma,” CURE; ...
Data shows iberdomide combination therapy delivers progression free survival and safety in relapsed and refractory multiple ...
A new legislative push to make ivermectin available without a prescription in Wyoming is drawing sharp criticism from medical professionals, who warn the move could not only endanger ...
Intismeran autogene with pembrolizumab shows a 49% reduction in recurrence or death risk in high-risk resected melanoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback